髋关节镜翻修术最低5年随访结果:与倾向匹配初次手术组的对照分析
本研究前瞻性纳入127例髋关节镜翻修术患者(平均随访72.8±23.3个月),并与254例倾向匹配的初次髋关节镜患者对照。翻修组所有患者报告结局评分(PROMS)均显著改善,达到最小临床重要差异(MCID)的比例较高,改善幅度与初次组相似。翻修组术前及术后PROMS均低于初次组,且转为关节置换的相对风险为2.6(95%CI 1.5-4.6)。
要点
- 髋关节镜翻修术后最低5年随访,所有PROMS及疼痛VAS均显著改善。
- 翻修组达到MCID比例高:mHHS 66.1%、HOS-SSS 68.4%、NAHS 66.9%、VAS 80.0%。
- 翻修组转为关节置换的相对风险是初次组的2.6倍(95%CI 1.5-4.6)。
核心结论
- 髋关节镜翻修术后最低5年随访显示所有PROMS及VAS显著改善,患者满意度高。
- 翻修组达到MCID的比例较高,改善幅度与倾向匹配的初次手术组相似。
- 初次髋关节镜患者术前及术后PROMS更高,转为关节置换的风险更低。
研究设计与样本
- 前瞻性队列研究,证据等级3级,数据收集于2008年6月至2014年4月。
- 纳入127例髋关节镜翻修术(113例患者),平均随访72.8±23.3个月。
- 排除Tönnis分级>1级及股骨头坏死、Legg-Calve-Perthes病、Ehlers-Danlos综合征、色素沉着绒毛结节性滑膜炎等患者。
- 翻修组与254例初次髋关节镜患者按性别、年龄、BMI和随访时间以1:2比例进行倾向匹配。
主要发现
- 翻修组女性占74.0%,平均年龄34.9±12.4岁,平均BMI 24.8±4.2。
- 翻修组所有PROMS均改善,达到MCID的比例:mHHS 66.1%、HOS-SSS 68.4%、NAHS 66.9%、VAS 80.0%。
- 翻修组术前及术后PROMS均低于倾向匹配的初次手术组。
- 两组间所有PROMS的改善幅度(Delta值)及达到MCID的比例无差异。
- 翻修组转为关节置换的相对风险为2.6(95%CI 1.5-4.6),高于初次手术组。
关键数值与推荐
- 翻修组达到MCID比例:mHHS 66.1%、HOS-SSS 68.4%、NAHS 66.9%、VAS 80.0%。
- 翻修组转为关节置换的相对风险为2.6(95%CI 1.5-4.6),对照为初次髋关节镜组。
临床怎么用
- 髋关节镜翻修术后最低5年随访可显著改善PROMS及疼痛,但术前及术后评分低于初次手术。
- 翻修术后达到MCID的比例较高,改善幅度与初次手术相似,但转为关节置换的风险更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a paucity of midterm outcome data on hip revision arthroscopic surgery. PURPOSE: (1) To report minimum 5-year patient-reported outcome measurement scores (PROMSs) in patients who underwent revision hip arthroscopy, (2) to compare minimum 5-year PROMSs with a propensity-matched control group that underwent primary hip arthroscopy, and (3) to compare the rate of achieving the minimal clinically important difference (MCID) at minimum 5-year follow-up between the revision group and the propensity-matched control primary group. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Data were prospectively collected between June 2008 and April 2014. Patients were included who underwent revision hip arthroscopy with preoperative and minimum 5-year follow-up scores for the modified Harris Hip Score (mHHS), Non-arthritic Hip Score (NAHS), Hip Outcome Score-Sports Specific Subscale (HOS-SSS), and visual analog scale (VAS) for pain. Patients with Tönnis grade >1 or with hip conditions such as avascular necrosis, Legg-Calve-Perthes disease, Ehlers-Danlos syndrome, and pigmented villonodular synovitis were excluded. A subanalysis was performed against a propensity-matched control group that underwent primary surgery. Groups were propensity matched in a 1:2 ratio for sex, age, body mass index, and follow-up time. RESULTS: A total of 127 revision arthroscopies (113 patients) were included, and the mean ± SD follow-up time was 72.8 ± 23.3 months. The revision group was 74.0% female, and the average age and body mass index were 34.9 ± 12.4 years and 24.8 ± 4.2, respectively. The revision group demonstrated improvement for all PROMSs and reached the MCID for the mHHS (66.1%), HOS-SSS (68.4%), NAHS (66.9%), and VAS (80.0%). All revision cases were propensity matched to 254 primary arthroscopy cases. PROMSs in the revision group were lower than those of the control group before and after surgery. Delta values were similar between groups for all PROMSs. There were no differences in rates of achieving the MCID. The relative risk of arthroplasty conversion was 2.6 (95% CI, 1.5-4.6) for the revision group as compared with the primary group. CONCLUSION: Significant improvement in all PROMSs, including the VAS, and high patient satisfaction at minimum 5-year follow-up were reported after revision hip arthroscopy. A high proportion of patients in the revision cohort reached the MCID for the mHHS, HOS-SSS, NAHS, and VAS, with similar rates and magnitudes of improvement relative to the control group. As expected, these data indicate that patients undergoing primary hip arthroscopy have higher PROMSs before and after surgery and lower rates of conversion to arthroplasty.
引用
- Maldonado DR, Kyin C, Rosinsky PJ, et al. Minimum 5-Year Outcomes for Revision Hip Arthroscopy With a Prospective Subanalysis Against a Propensity-Matched Control Primary Group. Am J Sports Med. 2021. PMID: 33999725. doi:10.1177/03635465211013006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。